NAXBYIN

Amphastar Pharmaceuticals, Inc.

Application Filed: 2020-07-21
Trademark Application Details
Trademark Logo NAXBYIN

Mark For: NAXBYIN™ trademark registration is intended to cover the categories of pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics. [all]

Status

2020-07-28 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number90064562
Mark Literal ElementsNAXBYIN
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationNEW APPLICATION PROCESSING 2020-07-24
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameThomas Y. Yee
Attorney Docket NumberAMPHA.024T

Timeline

2020-07-21Application Filed
2020-07-24Location: NEW APPLICATION PROCESSING
2020-07-24Status: Live/Pending
2020-07-24Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-07-24Transaction Date

Trademark Parties (Applicants & Owners)

Party: Amphastar Pharmaceuticals, Inc.
Address11570 Sixth St. Rancho Cucamonga, CALIFORNIA UNITED STATES 91730
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

ApplicationMULTI2020-07-21
DrawingJPEG2020-07-21

Attorney of Record

THOMAS Y. YEE
KNOBBE MARTENS OLSON & BEAR, LLP
2040 MAIN STREET, 14TH FLOOR
IRVINE, CA 92614

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED IN TRAM2020-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed